We implanted SMA-560 tumor cells into the right striatum of VM/Dk mice (day 0) and started the treatment on day 14 with the anti-CSF1R antibody 2G2, or the anti-PD1 antibody RMP1.14 or the respective control antibodies. This evidence concerns the gene RPL17 and neoplasm.